Podcast Index
Parcourez les podcasts par catégorie, ouvrez les épisodes récents et téléchargez l’audio pour l’écouter hors ligne.
Innovating Clinical Trials
Liam Eves and Ted Trafford
Phil At The Movies
Phil Walsh
The Nova Society
Dr. Mark George Bound, Dr. Scott Gerschwer, & Dr. Brooklynn Ann Welden
College App 101
Dr. Riley
Hidden Killers With Tony Brueski | True Crime News & Commentary
True Crime Today
Hospitality Daily Podcast
Josiah Mackenzie
Dans la scène musicale locale
L'équipe de Radio Laser
CHASE Your Dreams Podcast
Families Together, Inc.
New Mind
Sam Daghash
The Lockdown - Practical Privacy & Security
Ray Heffer
Metabolic Mind
Bret Scher
ABCs of Parenting Adult Children
James C Moffitt Jr.
False Start - College Football Podcast
John Buhler and Cody Williams
Ft Myers Beach - Good Neighbor
"Cabo" Jim Schaller
Muthership Creator Strategy
Helen & Juli Polise
60 Seconds of Hope with Horace McMillon
Horace McMillon
Dollars & Change: The Expert's Guide to Sustainable and Responsible Investing
Earth Equity Advisors
Las noticias de la SER
Felipe Areal
Las noticias de la SER
Felipe Areal
The VGBees Podcast
VGBees
Narcissism Exposed 360
Mentor Coach/ Pastor Zakiya Robinson
Shine FM
Touch Canada
Living without Limits Podcast
Angeline Hennessy-Thompson
xoxo godly girls
Tori & Abbi
KHCB On Demand
KHCB Network
The Light
Touch Canada
The Holistic Fertility Show
Mike Berkley
The Bridge Austin
The Bridge Austin
TAKEN TV Podcasts
Taken TV
Strategies for Success
Travis and Tyler McCrate
WPGM On Demand
Montrose Broadcasting
Torah History
Aryeh Ganz
Who Ordered the Pie? | Classic Rock Music History & Cocktails
Christopher Machado
Car Connection Workshop
Nile Jenkins
In Deep Geek
indeepgeek
The Daily Meditation with Brother Richard
Cutdown Studios
Bitcoin Liberty Live
Fritz
Tout
Liam Eves and Ted Trafford
Every trial starts with a number on a slide, patients needed, months allotted, a clean straight line on a chart. Liam and Ted pull that line apart in this episode, starting with Lasagna's Law: the 1970s observation that...
In this episode, Ted opens with a poem that captures the persistent, compounding burden on clinical trial sites: 50-page consents, non-functional tech, poached CRCs, financial holdbacks, and study designs that ask far t...
In this episode, Liam and Ted explore one of the most underexamined problems in clinical trial recruitment: patient motivation is not static. Drawing on real-world experience from a late-night participant funnel audit to...
In the final episode of our three-part series with Jill Fikowski, founder and CEO of Changemark Research + Evaluation, we get into one of the most persistent problems in clinical research: retention.Jill unpacks why part...
In Part 2 of our conversation with Jill Fikowski, founder and CEO of Changemark Research + Evaluation, we get into what good community engagement actually looks like in practice not as a checkbox, but as a core design pr...
Jill Fikowski, founder and CEO of Changemark Research + Evaluation, brings 25+ years of lived and professional experience in substance use and mental health research. In this episode we cover her work on the SALOME trial...
Clinical trials don’t become complex overnight, they get there one added process at a time.In this episode, Ted and Liam break down why the industry is so effective at adding new layers, but rarely takes the time to remo...
A 5 AM wake-up call. A perfectly planned setup. And a moment that never delivered.In this episode, Liam and Ted use a story about a missed “blood moon” to explore a deeper truth in clinical trials: expectations don’t alw...
What does it actually mean to put the patient first?In this episode, Liam and Ted explore the role of empathy and human connection in clinical trials. From rushed pre-screening calls to a powerful story of pausing a cons...
What makes a truly high-performing team?Inspired by the precision of Formula One pit crews, where the difference between winning and losing is measured in milliseconds, Ted and Liam explore what clinical trial teams can ...
In Part 3 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics discussing work-life balance, building social capital, and management vs. leadership.The conversation explores ...
In Part 2 of 3, Liam and Ted continue their conversation with Frank Watanabe, CEO of Arcutis Biotherapeutics, focusing on what it takes to hire and build high-performing teams in high-risk environments.Frank shares how h...
In this episode, Liam and Ted sit down with Frank Watanabe, President and CEO of Arcutis Biotherapeutics, to explore his journey from a Navy officer to a biotech executive and the leadership principles established along ...
A patient in a database is not a patient in a trial. So why do we keep treating feasibility like a headcount?Fresh from a week deep in feasibility work, Liam introduces four characters who show up and cause chaos in almo...
In elite sports, races are often won or lost in the transition, and Liam and Ted argue that the same is true in clinical trials. Drawing on the precision of Olympic relay racing, they make the case that the handoff point...
Using a David Letterman-inspired “Top 10” format, the conversation highlights common feasibility pitfalls faced by sponsors, CROs, and clinical trial sites, including overly complex questionnaires, unrealistic enrollment...
Why do clinical trials struggle even when teams are experienced and well-intentioned?In this episode, Liam and Ted explore why these outcomes are rarely about individual performance and far more often about system-level ...
Eligibility criteria are meant to bring clarity to clinical trials, but in practice, they often do the opposite.In this episode of Innovating Clinical Trials, Liam and Ted unpack how poorly worded, ambiguous, or misalign...
In this episode, Liam and Ted unpack why enrollment behaves more like an operating system rather than a standalone process. They explore the question of ownership, the role sponsors play through protocol design, and how ...
In this episode of Innovating Clinical Trials, Liam and Ted explore why building strong relationships with clinical trial sites requires more than dedicated relationship teams, it requires fixing problems at their source...
Remplissez le formulaire ci-dessous. Veillez à sélectionner à la fois Pays et Genres.
Envoyez-nous un message ci-dessous. Nous vous répondrons dans les 24 heures.